| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.5M | — |
| R&D Expense | $37.0M | -7.9% |
| SG&A Expense | $19.8M | +39.5% |
| Operating Income | -$44.3M | +18.5% |
| Income Tax | $0 | — |
| Net Income | -$36.0M | +34.1% |
| EPS (Basic) | -$1.04 | +52.9% |
| EPS (Diluted) | -$1.04 | +52.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.7M | -25.4% |
| Short-term Investments | $51.1M | -25.6% |
| Accounts Receivable | $2.0M | — |
| Current Assets | $81.3M | -22.7% |
| Total Assets | $89.4M | -34.8% |
| Current Liabilities | $9.7M | -28.3% |
| Total Liabilities | $13.4M | -51.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.1M | +9.6% |
| Capital Expenditures | $728K | -42.6% |
| Investing Cash Flow | $38.3M | +149.3% |
| Financing Cash Flow | -$2.6M | -102.1% |
| Free Cash Flow | -$44.9M | +10.4% |
| Stockholders' Equity |
| $76.0M |
| -30.7% |